1. Beckloff GL, Lerner HG, Forst D, Russo-Alesi FM, Gitomer S (1965) Hydroxyurea in biologic fluids: dose-concentration relationship. Cancer Chemother Rep 48: 57
2. Belliveau JF, Forastiere AA, Vogel W, Goren M, Posner M, O'Leary G (1987) Cisplatin pharmacokinetics: continuous infusion vs intermittent bolus in the treatment of head and neck cancer. Proc Am Assoc Cancer Res 28: 189
3. Belt RJ, Himmelstein KJ, Patton TF, Bannister SF, Sternson LA, Repta AJ (1979) Pharmacokinetics of non-protein-bound platinum species following administration ofcis-dichlorodiammineplatinum(II). Cancer Treat Rep 63: 1515
4. Belt RJ, Haas CD, Kennedy J, Taylor S (1980) Studies of hydroxyurea administered by continuous infusion. Cancer 46: 455
5. Creasey WA, Capizzi RL, DeConti RC (1970) Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea. Cancer Chemother Rep 54: 191